 | • レポートコード：QYR9N7660 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、精神神経疾患および治療のグローバル市場について調査・分析したレポートで、種類別（変性疾患、神経障害、精神病）、用途別（病院、診療所、研究センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・精神神経疾患および治療の世界市場規模 ・主要企業別市場シェア ・精神神経疾患および治療の世界市場規模：種類別（変性疾患、神経障害、精神病） ・精神神経疾患および治療の世界市場規模：用途別（病院、診療所、研究センター） ・精神神経疾患および治療のアメリカ市場規模（種類別、用途別） ・精神神経疾患および治療のヨーロッパ市場規模（種類別、用途別） ・精神神経疾患および治療の中国市場規模（種類別、用途別） ・精神神経疾患および治療の日本市場規模（種類別、用途別） ・精神神経疾患および治療の東南アジア市場規模（種類別、用途別） ・精神神経疾患および治療のインド市場規模（種類別、用途別） ・精神神経疾患および治療の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・精神神経疾患および治療の世界市場予測（2019年-2025年） ・精神神経疾患および治療の地域別市場予測（2019年-2025年） ... |
Neuropsychiatric disorder is a blanket medical term that encompasses a broad range of medical conditions that involve both neurology and psychiatry. Common neuropsychiatric disorders include seizures, attention deficits, cognitive deficits, palsies, uncontrolled anger, migraine headaches, addictions, eating disorders, depression, and anxiety and others. They can range widely in cause, course, and severity.The key component of neuropsychiatric disorders is that the symptoms tend to impact brain function, emotion and mood. These can range from problems with focus and learning in the case of ADHD to sadness, irritability, memory problems, mood problems, depression to a variety of other psychiatric and/or neurological symptoms. Medications, psychological and/or psychiatric therapy are common treatments for neuropsychiatric disorders. Specific treatments will vary based on the precise cause, clinical presentation and severity.
In 2018, the global Neuropsychiatric Disorders And Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Neuropsychiatric Disorders And Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Neuropsychiatric Disorders And Treatment development in United States, Europe and China.
The key players covered in this study
Astrazeneca
Glaxosmithkline
Universal Health Services
Boehringer Ingelheim
Eli Lilly
…
Market segment by Type, the product can be split into
Degenerative Diseases
Neurotic Disorders
Psychosis
Market segment by Application, split into
Hospitals
Clinics
Research Centres
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Neuropsychiatric Disorders And Treatment status, future forecast, growth opportunity, key market and key players.
To present the Neuropsychiatric Disorders And Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Neuropsychiatric Disorders And Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Neuropsychiatric Disorders And Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Degenerative Diseases
1.4.3 Neurotic Disorders
1.4.4 Psychosis
1.5 Market by Application
1.5.1 Global Neuropsychiatric Disorders And Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Research Centres
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Neuropsychiatric Disorders And Treatment Market Size
2.2 Neuropsychiatric Disorders And Treatment Growth Trends by Regions
2.2.1 Neuropsychiatric Disorders And Treatment Market Size by Regions (2014-2025)
2.2.2 Neuropsychiatric Disorders And Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Neuropsychiatric Disorders And Treatment Market Size by Manufacturers
3.1.1 Global Neuropsychiatric Disorders And Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Neuropsychiatric Disorders And Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Neuropsychiatric Disorders And Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Neuropsychiatric Disorders And Treatment Key Players Head office and Area Served
3.3 Key Players Neuropsychiatric Disorders And Treatment Product/Solution/Service
3.4 Date of Enter into Neuropsychiatric Disorders And Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Neuropsychiatric Disorders And Treatment Market Size by Type (2014-2019)
4.2 Global Neuropsychiatric Disorders And Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Neuropsychiatric Disorders And Treatment Market Size (2014-2019)
5.2 Neuropsychiatric Disorders And Treatment Key Players in United States
5.3 United States Neuropsychiatric Disorders And Treatment Market Size by Type
5.4 United States Neuropsychiatric Disorders And Treatment Market Size by Application
6 Europe
6.1 Europe Neuropsychiatric Disorders And Treatment Market Size (2014-2019)
6.2 Neuropsychiatric Disorders And Treatment Key Players in Europe
6.3 Europe Neuropsychiatric Disorders And Treatment Market Size by Type
6.4 Europe Neuropsychiatric Disorders And Treatment Market Size by Application
7 China
7.1 China Neuropsychiatric Disorders And Treatment Market Size (2014-2019)
7.2 Neuropsychiatric Disorders And Treatment Key Players in China
7.3 China Neuropsychiatric Disorders And Treatment Market Size by Type
7.4 China Neuropsychiatric Disorders And Treatment Market Size by Application
8 Japan
8.1 Japan Neuropsychiatric Disorders And Treatment Market Size (2014-2019)
8.2 Neuropsychiatric Disorders And Treatment Key Players in Japan
8.3 Japan Neuropsychiatric Disorders And Treatment Market Size by Type
8.4 Japan Neuropsychiatric Disorders And Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Neuropsychiatric Disorders And Treatment Market Size (2014-2019)
9.2 Neuropsychiatric Disorders And Treatment Key Players in Southeast Asia
9.3 Southeast Asia Neuropsychiatric Disorders And Treatment Market Size by Type
9.4 Southeast Asia Neuropsychiatric Disorders And Treatment Market Size by Application
10 India
10.1 India Neuropsychiatric Disorders And Treatment Market Size (2014-2019)
10.2 Neuropsychiatric Disorders And Treatment Key Players in India
10.3 India Neuropsychiatric Disorders And Treatment Market Size by Type
10.4 India Neuropsychiatric Disorders And Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Neuropsychiatric Disorders And Treatment Market Size (2014-2019)
11.2 Neuropsychiatric Disorders And Treatment Key Players in Central & South America
11.3 Central & South America Neuropsychiatric Disorders And Treatment Market Size by Type
11.4 Central & South America Neuropsychiatric Disorders And Treatment Market Size by Application
12 International Players Profiles
12.1 Astrazeneca
12.1.1 Astrazeneca Company Details
12.1.2 Company Description and Business Overview
12.1.3 Neuropsychiatric Disorders And Treatment Introduction
12.1.4 Astrazeneca Revenue in Neuropsychiatric Disorders And Treatment Business (2014-2019)
12.1.5 Astrazeneca Recent Development
12.2 Glaxosmithkline
12.2.1 Glaxosmithkline Company Details
12.2.2 Company Description and Business Overview
12.2.3 Neuropsychiatric Disorders And Treatment Introduction
12.2.4 Glaxosmithkline Revenue in Neuropsychiatric Disorders And Treatment Business (2014-2019)
12.2.5 Glaxosmithkline Recent Development
12.3 Universal Health Services
12.3.1 Universal Health Services Company Details
12.3.2 Company Description and Business Overview
12.3.3 Neuropsychiatric Disorders And Treatment Introduction
12.3.4 Universal Health Services Revenue in Neuropsychiatric Disorders And Treatment Business (2014-2019)
12.3.5 Universal Health Services Recent Development
12.4 Boehringer Ingelheim
12.4.1 Boehringer Ingelheim Company Details
12.4.2 Company Description and Business Overview
12.4.3 Neuropsychiatric Disorders And Treatment Introduction
12.4.4 Boehringer Ingelheim Revenue in Neuropsychiatric Disorders And Treatment Business (2014-2019)
12.4.5 Boehringer Ingelheim Recent Development
12.5 Eli Lilly
12.5.1 Eli Lilly Company Details
12.5.2 Company Description and Business Overview
12.5.3 Neuropsychiatric Disorders And Treatment Introduction
12.5.4 Eli Lilly Revenue in Neuropsychiatric Disorders And Treatment Business (2014-2019)
12.5.5 Eli Lilly Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Neuropsychiatric Disorders And Treatment Key Market Segments
Table Key Players Neuropsychiatric Disorders And Treatment Covered
Table Global Neuropsychiatric Disorders And Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Neuropsychiatric Disorders And Treatment Market Size Market Share by Type 2014-2025
Figure Degenerative Diseases Figures
Table Key Players of Degenerative Diseases
Figure Neurotic Disorders Figures
Table Key Players of Neurotic Disorders
Figure Psychosis Figures
Table Key Players of Psychosis
Table Global Neuropsychiatric Disorders And Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Research Centres Case Studies
Figure Neuropsychiatric Disorders And Treatment Report Years Considered
Table Global Neuropsychiatric Disorders And Treatment Market Size 2014-2025 (Million US$)
Figure Global Neuropsychiatric Disorders And Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Neuropsychiatric Disorders And Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Neuropsychiatric Disorders And Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Neuropsychiatric Disorders And Treatment Market Share by Regions 2014-2019
Figure Global Neuropsychiatric Disorders And Treatment Market Share by Regions 2014-2019
Figure Global Neuropsychiatric Disorders And Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Neuropsychiatric Disorders And Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Neuropsychiatric Disorders And Treatment Market Share by Manufacturers (2014-2019)
Figure Global Neuropsychiatric Disorders And Treatment Market Share by Manufacturers in 2018
Table Global Neuropsychiatric Disorders And Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Neuropsychiatric Disorders And Treatment Product/Solution/Service
Table Date of Enter into Neuropsychiatric Disorders And Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Neuropsychiatric Disorders And Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Neuropsychiatric Disorders And Treatment Market Size Share by Type (2014-2019)
Figure Global Neuropsychiatric Disorders And Treatment Market Size Market Share by Type (2014-2019)
Table Global Neuropsychiatric Disorders And Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Neuropsychiatric Disorders And Treatment Market Size Share by Application (2014-2019)
Figure Global Neuropsychiatric Disorders And Treatment Market Size Market Share by Application (2014-2019)
Figure Global Neuropsychiatric Disorders And Treatment Revenue Market Share by Application in 2018
Figure United States Neuropsychiatric Disorders And Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Neuropsychiatric Disorders And Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Neuropsychiatric Disorders And Treatment Market Share (2018-2019)
Table United States Neuropsychiatric Disorders And Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Neuropsychiatric Disorders And Treatment Market Share by Type (2014-2019)
Table United States Neuropsychiatric Disorders And Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Neuropsychiatric Disorders And Treatment Market Share by Application (2014-2019)
Figure Europe Neuropsychiatric Disorders And Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Neuropsychiatric Disorders And Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Neuropsychiatric Disorders And Treatment Market Share (2018-2019)
Table Europe Neuropsychiatric Disorders And Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Neuropsychiatric Disorders And Treatment Market Share by Type (2014-2019)
Table Europe Neuropsychiatric Disorders And Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Neuropsychiatric Disorders And Treatment Market Share by Application (2014-2019)
Figure China Neuropsychiatric Disorders And Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Neuropsychiatric Disorders And Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Neuropsychiatric Disorders And Treatment Market Share (2018-2019)
Table China Neuropsychiatric Disorders And Treatment Market Size by Type (2014-20189) (Million US$)
Table China Neuropsychiatric Disorders And Treatment Market Share by Type (2014-2019)
Table China Neuropsychiatric Disorders And Treatment Market Size by Application (2014-2019) (Million US$)
Table China Neuropsychiatric Disorders And Treatment Market Share by Application (2014-2019)
Figure Japan Neuropsychiatric Disorders And Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Neuropsychiatric Disorders And Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Neuropsychiatric Disorders And Treatment Market Share (2018-2019)
Table Japan Neuropsychiatric Disorders And Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Neuropsychiatric Disorders And Treatment Market Share by Type (2014-2019)
Table Japan Neuropsychiatric Disorders And Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Neuropsychiatric Disorders And Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Neuropsychiatric Disorders And Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Neuropsychiatric Disorders And Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Neuropsychiatric Disorders And Treatment Market Share (2018-2019)
Table Southeast Asia Neuropsychiatric Disorders And Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Neuropsychiatric Disorders And Treatment Market Share by Type (2014-2019)
Table Southeast Asia Neuropsychiatric Disorders And Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Neuropsychiatric Disorders And Treatment Market Share by Application (2014-2019)
Figure India Neuropsychiatric Disorders And Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Neuropsychiatric Disorders And Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Neuropsychiatric Disorders And Treatment Market Share (2018-2019)
Table India Neuropsychiatric Disorders And Treatment Market Size by Type (2014-2019) (Million US$)
Table India Neuropsychiatric Disorders And Treatment Market Share by Type (2014-2019)
Table India Neuropsychiatric Disorders And Treatment Market Size by Application (2014-2019) (Million US$)
Table India Neuropsychiatric Disorders And Treatment Market Share by Application (2014-2019)
Figure Central & South America Neuropsychiatric Disorders And Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Neuropsychiatric Disorders And Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Neuropsychiatric Disorders And Treatment Market Share (2018-2019)
Table Central & South America Neuropsychiatric Disorders And Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Neuropsychiatric Disorders And Treatment Market Share by Type (2014-2019)
Table Central & South America Neuropsychiatric Disorders And Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Neuropsychiatric Disorders And Treatment Market Share by Application (2014-2019)
Table Astrazeneca Company Details
Table Astrazeneca Revenue in Neuropsychiatric Disorders And Treatment Business (2014-2019) (Million US$)
Figure Astrazeneca Revenue Growth Rate in Neuropsychiatric Disorders And Treatment Business (2014-2019)
Table Astrazeneca Recent Development
Table Glaxosmithkline Company Details
Table Glaxosmithkline Revenue in Neuropsychiatric Disorders And Treatment Business (2014-2019)(Million US$)
Figure Glaxosmithkline Revenue Growth Rate in Neuropsychiatric Disorders And Treatment Business (2014-2019)
Table Glaxosmithkline Recent Development
Table Universal Health Services Company Details
Table Universal Health Services Revenue in Neuropsychiatric Disorders And Treatment Business (2014-2019)(Million US$)
Figure Universal Health Services Revenue Growth Rate in Neuropsychiatric Disorders And Treatment Business (2014-2019)
Table Universal Health Services Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Neuropsychiatric Disorders And Treatment Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Neuropsychiatric Disorders And Treatment Business (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Neuropsychiatric Disorders And Treatment Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Neuropsychiatric Disorders And Treatment Business (2014-2019)
Table Eli Lilly Recent Development
Table Global Neuropsychiatric Disorders And Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Neuropsychiatric Disorders And Treatment Market Size Share by Regions (2019-2025)
Figure Global Neuropsychiatric Disorders And Treatment Market Size Share by Regions in 2025
Figure United States Neuropsychiatric Disorders And Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Neuropsychiatric Disorders And Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Neuropsychiatric Disorders And Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Neuropsychiatric Disorders And Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Neuropsychiatric Disorders And Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Neuropsychiatric Disorders And Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Neuropsychiatric Disorders And Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Neuropsychiatric Disorders And Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Neuropsychiatric Disorders And Treatment Market Size by Product (2019-2025)
Figure Global Neuropsychiatric Disorders And Treatment Market Size by Product in 2025
Table Global Neuropsychiatric Disorders And Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Neuropsychiatric Disorders And Treatment Market Size by Application (2019-2025)
Figure Global Neuropsychiatric Disorders And Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の前頭側頭障害の治療市場：市場規模・現状・予測 In 2018, the global Frontotemporal Disorders Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Frontotemporal Disorders Treatment status, future forecast, growth opportunity, …- 世界の物質使用障害（SUD）の治療市場：市場規模・現状・予測 A substance use disorder (SUD), also known as a drug use disorder, is a medical condition in which the use of one or more substances leads to a clinically significant impairment or distress. Theres is habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcoho…
- 世界の膝・股関節障害市場：市場規模・現状・予測 Knee and hip are complex joints in the body. The knee joins the thigh bone (femur) to the shin bone (tibia), whereas the hip joint is a ball-socket synovial joint formed between the os coxa (hip bone) and the femur. To treat knee and hip disorders, implants and surgeries are performed so as to keep …
- 世界の副甲状腺疾患市場：市場規模・現状・予測 Parathyroid disorders lead to abnormal levels of calcium in the blood that can cause brittle bones, kidney stones, fatigue, weakness, and other problems.Patients with chronic kidney disease may develop secondary hyperparathyroidism with resultant chronic kidney disease-mineral and bone disorder. Hyp…
- 世界のパニック障害市場：市場規模・現状・予測 Panic disorder is an anxiety disorder characterized by reoccurring unexpected panic attacks.Panic disorder is usually treated with counselling and medications. The type of counselling used is typically cognitive behavioral therapy which is effective in more than half of people. Medications used incl…